Treatment of sexually transmitted infections in women

Infect Dis Clin North Am. 2008 Dec;22(4):665-691. doi: 10.1016/j.idc.2008.05.009.

Abstract

Sexually transmitted infections remain a major public health concern in the United States. An estimated 19 million infections occur each year. The economic burden imposed by sexually transmitted infections is impressive: direct medical costs are estimated to be as high as $15.5 billion annually. Women and infants disproportionately bear the long-term consequences of sexually transmitted diseases. This article briefly introduces various infections, reviews new diagnostic information, and presents the latest guidelines for therapy. All recommended and alternative regimens are drawn from the most recent Centers for Disease Control and Prevention treatment guidelines and recent updates.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / therapeutic use*
  • Counseling
  • Female
  • Humans
  • Incidence
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / epidemiology
  • Pregnancy Complications, Infectious / prevention & control
  • Sexually Transmitted Diseases / drug therapy*
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / etiology
  • Sexually Transmitted Diseases / prevention & control
  • United States / epidemiology
  • Women's Health*

Substances

  • Anti-Infective Agents